Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating type 1 interferon (IFN)-mediated disease using a subcutaneous dosing regimen comprising anifrolumab

Method of treating type 1 interferon (IFN)-mediated disease using a subcutaneous dosing regimen comprising anifrolumab

US Patent 12060429 · Granted Aug 13, 2024

Estimated economic value: $115,818,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Refill and dosage management devices and associated systems and methods for use 2025
Methods for determining treatment for cancer patients2025
Computerized oral prescription administration with refillable medication dispens2025
Computerized oral prescription administration devices and associated systems and2024
Anti-B7-H1 antibodies for treating tumors2023
Methods for determining treatment for cancer patients2023
Computerized oral prescription administration with refillable medication dispens2022
Computerized oral prescription administration devices and associated systems and2021
Validating authorization for use of a set of features of a device2021
Anti-B7-H1 antibodies for treating tumors2020
Refill and dosage management devices and associated systems and methods for use 2020
Subsystem for authorization and activation of features2020